滬銅收高創16個月來最大單月漲幅
- 0001年1月1日
1
注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
代號 | 交易所 | 貨幣 | ||
---|---|---|---|---|
AMGN | NASDAQ | USD | 即時 | |
AMGN | BIVA | MXN | 延遲 | |
AMGN | 墨西哥 | MXN | 延遲 | |
AAMGN | 米蘭 | EUR | 即時 | |
AMGN | TradeGate | EUR | 延遲 | |
AMGN | 法蘭克福 | EUR | 延遲 | |
AMGN | Xetra | EUR | 延遲 | |
AMGN | 布宜諾斯艾利斯 | ARS | 延遲 | |
AMGN34 | B3 | BRL | 延遲 | |
4332 | 香港 | HKD | 延遲 | |
AMGN | 維也納 | EUR | 即時 |
安進公司是一家生物技術公司。該公司探索、開發、製造及銷售人類治療藥品。該公司通過人類治療藥品業務運營。該公司銷售的藥品包括:Neulasta(pegfilgrastim),Aranesp(darbepoetin alfa)及EPOGEN(epoetin alfa)等促紅細胞生成劑,Sensipar/Mimpara(cinacalcet),XGEVA(denosumab),Prolia(denosumab),NEUPOGEN(filgrastim),和Vectibix(panitumumab)、Nplate(romiplostim)及Corlanor(ivabradine)等。該公司專注於研髮用於治療腫瘤及血液病、心血管病、炎症、骨骼病、腎髒病及神經疾病等嚴重疾病的人類藥物。該公司研發的處於第III階段的產品包括用於發作性偏頭痛的Erenumab,骨髓增生異常綜合徵的Aranesp,急性淋巴細胞白血病的BLINCYTO和轉移性黑色素瘤的IMLYGIC。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Robert A. Bradway | 58 | 2007 | Chairman, CEO & President |
Robert A. Eckert | 69 | 2012 | Lead Independent Director |
Greg C. Garland | 66 | 2013 | Independent Director |
Tyler E. Jacks | 62 | 2012 | Independent Director |
Brian J. Druker | 68 | 2018 | Independent Director |
Ellen J. Kullman | 67 | 2016 | Independent Director |
David Baltimore | 85 | 1999 | Co-Chair of Scientific Advisory Board |
Wanda M. Austin | 69 | 2017 | Independent Director |
Amy E. Miles | 56 | 2020 | Independent Director |
S. Omar Ishrak | 67 | 2021 | Independent Director |
Diane J. Mathis | - | - | Member of Scientific Advisory Board of Inflammation |
Ronald D. Sugar | 74 | 2010 | Independent Director |
R. Sanders Williams | 74 | 2014 | Independent Director |
Alexander Marson | - | 2022 | Member of Scientific Advisory Board of Inflammation |
Arlene Sharpe | - | 2022 | Member of Scientific Advisory Board of Inflammation |
Charles M. Holley | 66 | 2017 | Independent Director |
Lillian L. Siu | - | 2022 | Member of Scientific Advisory Board of Oncology |
S. Gail Eckhardt | - | 2022 | Member of Scientific Advisory Board of Oncology |
Richard O. Hynes | - | - | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
Maria T. Abreu | - | 2022 | Member of Scientific Advisory Board of Inflammation |
Michael V. Drake | 72 | 2022 | Independent Director |
Emma Guttman-Yassky | - | 2022 | Member of Scientific Advisory Board of Inflammation |
Meilan Han | - | 2022 | Member of Scientific Advisory Board of Inflammation |
Dirk Jäger | - | - | Member of Scientific Advisory Board of Oncology |
Robert S. Negrin | - | - | Member of Scientific Advisory Board of Oncology |
Daniel P. Kelly | - | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
Robert Tjian | 74 | - | Member of Scientific Advisory Board Member of Research Trends & Emerging Technologies |
Siwen Hu-Lieskovan | - | - | Member of Scientific Advisory Board of Oncology |
Frank P. McCormick | 73 | - | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
Ronald M. Evans | 74 | - | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
John Kuriyan | - | - | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
Jeffery D. Molkentin | - | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
George Georgiou | 64 | 2023 | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
David Alan Kass | - | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
E. Dale Abel | - | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
Elizabeth McNally | - | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
Jonathan S. Weissman | - | - | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
Drew Mark Pardoll | - | - | Member of Scientific Advisory Board of Oncology |
Marlene Rabinovitch | - | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
Dean Sheppard | - | 2022 | Member of Scientific Advisory Board of Inflammation |
Alexander Rudensky | - | 2022 | Member of Scientific Advisory Board of Inflammation |
Antoni Ribas | - | - | Member of Scientific Advisory Board of Oncology |
Benoit Van den Eynde | - | - | Member of Scientific Advisory Board of Oncology |
David J. Anderson | - | - | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
Peter Libby | 76 | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
Ruslan Medzhitov | - | - | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
Daniel Joshua Drucker | - | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
Charles Elliott Sigal | 72 | - | Co-Chair of the Scientific Advisory Board |
Thomas Quertermous | 72 | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核